EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,465,178 | -49.0% | 1,019,035 | +10.2% | 0.00% | -100.0% |
| Q2 2023 | $6,794,959 | -26.8% | 924,484 | +3.1% | 0.00% | 0.0% |
| Q1 2023 | $9,287,267 | +91517.5% | 896,454 | +4.4% | 0.00% | 0.0% |
| Q4 2022 | $10,137 | -99.9% | 858,414 | +2.6% | 0.00% | -66.7% |
| Q3 2022 | $17,556,000 | -32.0% | 836,420 | +0.5% | 0.00% | -25.0% |
| Q2 2022 | $25,823,000 | -23.1% | 831,951 | +1.7% | 0.00% | 0.0% |
| Q1 2022 | $33,572,000 | -8.4% | 817,647 | -3.0% | 0.00% | 0.0% |
| Q4 2021 | $36,636,000 | -11.1% | 842,798 | +2.4% | 0.00% | -33.3% |
| Q3 2021 | $41,211,000 | -22.4% | 823,072 | -2.3% | 0.01% | -14.3% |
| Q2 2021 | $53,092,000 | -30.6% | 842,877 | +2.3% | 0.01% | -41.7% |
| Q1 2021 | $76,551,000 | +23.9% | 823,932 | +19.5% | 0.01% | +20.0% |
| Q4 2020 | $61,800,000 | -8.0% | 689,734 | +6.1% | 0.01% | -23.1% |
| Q3 2020 | $67,170,000 | +29.7% | 650,061 | -0.7% | 0.01% | +18.2% |
| Q2 2020 | $51,770,000 | +39.5% | 654,665 | +2.1% | 0.01% | +10.0% |
| Q1 2020 | $37,104,000 | -42.8% | 641,292 | -46.7% | 0.01% | +42.9% |
| Q4 2019 | $64,882,000 | +114.7% | 1,202,654 | +108.0% | 0.01% | 0.0% |
| Q3 2019 | $30,224,000 | +5.6% | 578,130 | -2.4% | 0.01% | 0.0% |
| Q2 2019 | $28,617,000 | +4.2% | 592,373 | +9.0% | 0.01% | 0.0% |
| Q1 2019 | $27,461,000 | -55.6% | 543,584 | -47.9% | 0.01% | -30.0% |
| Q4 2018 | $61,864,000 | +100.9% | 1,043,632 | +123.1% | 0.01% | +11.1% |
| Q3 2018 | $30,796,000 | +55.3% | 467,830 | +19.1% | 0.01% | +50.0% |
| Q2 2018 | $19,834,000 | +12.2% | 392,859 | +17.0% | 0.01% | 0.0% |
| Q1 2018 | $17,683,000 | +14.6% | 335,881 | +1.2% | 0.01% | +20.0% |
| Q4 2017 | $15,424,000 | +15.8% | 331,927 | +0.8% | 0.01% | 0.0% |
| Q3 2017 | $13,323,000 | +24.5% | 329,391 | +4.4% | 0.01% | +25.0% |
| Q2 2017 | $10,697,000 | +17.2% | 315,459 | +0.4% | 0.00% | 0.0% |
| Q1 2017 | $9,124,000 | -3.6% | 314,198 | +9.0% | 0.00% | 0.0% |
| Q4 2016 | $9,465,000 | +9.2% | 288,245 | +4.9% | 0.00% | 0.0% |
| Q3 2016 | $8,664,000 | +24.1% | 274,819 | +10.6% | 0.00% | 0.0% |
| Q2 2016 | $6,984,000 | -11.5% | 248,391 | +14.5% | 0.00% | 0.0% |
| Q1 2016 | $7,888,000 | -7.1% | 217,017 | +2.2% | 0.00% | -20.0% |
| Q4 2015 | $8,495,000 | +34.5% | 212,337 | -4.3% | 0.01% | +25.0% |
| Q3 2015 | $6,317,000 | -8.0% | 221,769 | +6.4% | 0.00% | 0.0% |
| Q2 2015 | $6,869,000 | +22.8% | 208,494 | +7.2% | 0.00% | +33.3% |
| Q1 2015 | $5,594,000 | +10.8% | 194,512 | +4.9% | 0.00% | 0.0% |
| Q4 2014 | $5,049,000 | +28.2% | 185,456 | +0.3% | 0.00% | 0.0% |
| Q3 2014 | $3,939,000 | +5.5% | 184,886 | +11.2% | 0.00% | +50.0% |
| Q2 2014 | $3,732,000 | -23.1% | 166,201 | -13.5% | 0.00% | -33.3% |
| Q1 2014 | $4,852,000 | +34.2% | 192,053 | +22.1% | 0.00% | 0.0% |
| Q4 2013 | $3,615,000 | +30.2% | 157,267 | +7.9% | 0.00% | +50.0% |
| Q3 2013 | $2,776,000 | +37.7% | 145,702 | +4.2% | 0.00% | 0.0% |
| Q2 2013 | $2,016,000 | – | 139,838 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |